| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On November 21, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2007D-0310
|
| Companion to Guidance for Industry on Pharmacogenomic Data
|
|
|
|
|
| 2007E-0256
|
| Patent Extension Application for TEKTURNA (Aliskiren hemifumarate), U.S. Patent No. 5,559,111
|
|
|
|
|
| 2007E-0424
|
| Patent Extension Application for LUCENTIS (ranibizumab), U.S. Patent No. 6,407,213
|
|
|
|
|
| 2007E-0425
|
| Patent Extension Application for LUCENTIS (ranibizumab), U.S. Patent No. 6,884,879
|
|
| |
|
| 2007D-0310
|
| Companion to Guidance for Industry on Pharmacogenomic Data
|
|
|
|
|
| C 3
|
| sanofi aventis
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007E-0256
|
| Patent Extension Application for TEKTURNA (Aliskiren hemifumarate), U.S. Patent No. 5,559,111
|
|
|
|
|
| LET 2
|
| FDA/CDER to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
| |
|
| 2007E-0424
|
| Patent Extension Application for LUCENTIS (ranibizumab), U.S. Patent No. 6,407,213
|
|
|
|
|
| LET 2
|
| FDA/CDER to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007E-0425
|
| Patent Extension Application for LUCENTIS (ranibizumab), U.S. Patent No. 6,884,879
|
|
|
|
|
| LET 2
|
| FDA/CDER to U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|